DatasetName,CLASRP_S(1232) CLASRP_S(282) CLASRP_S(285) CLASRP_S(288) CLASRP_S(291) CLASRP_S(294) CLASRP_S(540) CLASRP_S(547) CLASRP_T(319) CLASRP_T(98),CLASRP_S(101) CLASRP_S(3) CLASRP_S(315) CLASRP_S(331) CLASRP_S(335) CLASRP_S(454) CLASRP_S(456) CLASRP_S(499) CLASRP_S(501) CLASRP_S(531) CLASRP_S(626) CLASRP_S(645) CLASRP_S(647) CLASRP_S(649) CLASRP_S(667) CLASRP_S(669) CLASRP_S(7) CLASRP_T(542) CLASRP_T(573) CLASRP_T(93)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,0.45259864380885684
SR2019_MCF7_Biol_repl_3,0.598473410865224,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.4449327019815895
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.6141962930046041,0.45458404700040633
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.6390592482666275,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.46182108185224957
SR2019_MDAMB231_Biol_repl_4,0.5953609114668842,
GF2025_P2_Sph,0.6010440289323516,0.4512706669529167
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.6128823090273186,0.4310516904404551
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.6178665678946815,0.4416163276957512
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.6071884229618487,0.45535767864490395
WZ2023_Pu_010_30min,0.6598993327069916,0.45795846694922704
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.6268576056092909,0.4567644314473017
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.6249533601581414,0.455829154244768
FSO2013_Ratio M/L normalized Rep3___3,,0.4484298970470856
AH2018_TMTMS3_1_C,0.6259427592938549,0.46016208102842304
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.6030877073788297,0.4453586772738376
AH2018_SILAC_MR_2_N,0.6175214564257475,0.4490632800129969
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5694529825499868,0.4568540602596706
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,0.46029309607623325
EP2017_Pervanadate R#3 normalized log2 ratio,0.5947286630602424,0.455687044474056
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5984998464365465,0.4506651312766922
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.6441671186251235,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.6475285220456469,0.4493854391015792
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.6176812835115523,0.4419197222801797
KBE2022_Log2_Ex_34_U,0.6142836527132274,0.4354564858495384
WZ2023_Pu_005_10min,0.6528748589632057,0.44903937692625506
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,0.604249393976166,
WZ2023_Pu_025_30min,0.6534112225996044,0.4594444359251921
AH2018_SILAC_MR_2_X,0.6165549589184425,0.4509682199823969
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.6062746325713287,0.4660579543517008
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.6347664302775323,0.4520098333537351
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.6261303031388444,0.45292789780722575
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.6177296694787424,0.4454559150801389
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,0.6198887628700825,0.45845766587112013
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.6116321547284032,0.44269757902427703
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6561614125450482,0.4476137863501049
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.6170189631406003,0.4457582526331505
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.636201079798073,0.45574796559785213
FSO2013_Ratio H/L normalized Rep2,,0.46966010919446666
WZ2023_Pu_005_20min,0.6588140409087881,0.4517225310748604
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.625135223973707,0.4617246823653229
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.6244584750588434,0.46082180855746363
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,0.45190473489100513
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.44609553689903336
CK2022_1 200-1,0.6244681733403645,0.44803607825649705
PG2020_Intensity Mock_10h_D,0.6127587816181576,0.4403523619535151
SR2019_MCF10A_Biol_repl_2,0.5983404273099276,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5732314501080478,0.4560714296683761
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.6285954107035769,0.44510116491957596
PG2020_Intensity 2h_C,0.6196650974876461,0.45164682670533873
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.6458186201943773,
KBE2022_Log2_Ex_8_T,0.6082510134899015,0.45345178467077735
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.6075036350484684,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.6238276907000169,0.45823936558311446
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.6112154106644855,0.4477551549611037
HH2022_Reporter intensity 8,0.610032363940874,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,0.45645416263025484
AH2018_TMTMS3_2_N,0.6197082973791951,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.6282532160260997,0.4533766740083952
YA2020_Reporter_intensity_Normal_No.1,0.6141955667186885,0.4495134226687143
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.6014392531360488,0.4576136620341689
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5939287419774053,0.44882839035259636
HS2024_8_I_T3,,
CF2017_EOC 3,0.619584305259402,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,0.600987573854066,0.4590908197762709
WZ2023_Pu_010_20min,0.6543560663918739,0.4578599850276407
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,0.44608812173115486
KS2014_Intensity N3,0.6359094650060377,0.46123749692784244
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.6146452638359248,0.45467329981728477
FSO2013_Ratio H/M normalized Rep2,,0.45101711954616625
RAM2015_Log2 A,0.5971908399884827,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.6107450896513363,
KS2014_Intensity E15_2,0.6337499209490803,0.4541496103643648
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5796074592437437,0.441628917991894
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,0.5816895288489964,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.6310786929106385,0.4530686923042433
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.616749208209549,0.42466489587799183
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.6178792663594391,0.4498838602319962
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.6173872467030984,0.44348496227980505
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.6102348268416994,0.45600566304922907
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.6056283013209287,0.45744095458798373
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.452672824711921
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.6152693031829803,0.44411839610580844
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.5964205546667761,0.4416441049337275
FSO2013_Ratio M/L normalized Rep2,,0.45998900788400326
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.6159303165789527,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.6045263790667226,0.4411990455594001
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.6246434373604566,0.45584110341583095
DL2023_control-1,,
AR2021_ALG 10 μM,0.6103010805359755,0.46084100963679087
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.6162597231282227,0.4556672936363563
EJN2021_4_Rest_Ins,,
RN2012_H05,0.6545292921029208,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.6269559832052235,0.45777417394358116
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.6338838853364627,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.6146403593484461,0.45994598532263
JW2021_After_3,,
GF2025_P8_Sph,0.6021024365611608,0.44546481011380656
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.6172958864829103,0.4441421583414895
CK2022_11 200-1,0.6276155673870629,0.45961024542517437
CK2022_12 200-1,0.6299986564311462,0.46163964814029335
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.6072614494900582,
WZ2023_Su_010_20min,0.6576988625122976,0.45819760630720097
AH2018_TMTMS2_2_N,0.6272154810026189,0.46128333391800924
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.6151515713112865,0.4406486347706621
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.45255288653792763
AH2018_TMTMS3_Pool,0.6233526352079843,
KS2014_Intensity N4,0.6383123877530098,0.45615553441188783
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.6122787548753157,
CK2022_14 200-1,0.6312189629969407,0.4580092979281907
SR2019_Hs578T_Biol_repl_1,0.6023920445614244,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.6271600021593486,
AST2020_anti-CD3+PDL2.2,0.6178421866642425,0.44279832800408025
PG2020_Intensity Mock_10h_A,0.6178828915862652,0.4475731955737901
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.44331902513372484
GF2025_P1_Adh,0.6102915141228114,0.4589527749002758
GF2025_P1_Sph,0.6076569050820254,0.44990327999746943
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.6529361964927813,0.4537596541949604
CF2017_EOC 1,0.5907718698681006,
CK2022_3 200-1,0.6249483610213503,0.44637292450903143
AH2018_LFQ_IT_3_C,0.6191209611455958,0.4476149249213156
SR2019_Hs578T_Biol_repl_2,0.5977315885572206,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,0.5899469730408802,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.6252882365220274,0.44605330145878286
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.44532346922254035
AR2021_ALG 1 μM,0.5909740355019311,0.457318464904905
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5943956755649573,0.43981945452533894
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.6162982386914909,0.45481585931465673
CK2022_9 16-1,,0.4423411825554909
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,0.6152011539549118,
CK2022_13 200-1,0.6309794985102715,0.45646859237936016
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5772050412535041,
CK2022_16 16-1,,0.4463052411068119
FS2019_db/db3,,0.45716840163852634
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.6590212579373077,0.448779910380199
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.6157960935034076,0.43921596185543155
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.6169899898792606,0.4457392668609225
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.6260379825582867,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.6182650717583733,0.4505567446783276
AH2018_LFQ_M_1_N,0.625777929646331,0.45992696134885946
KBE2022_Log2_Ex_27_U,0.6096303708202295,0.4550313428597431
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.6154296126635335,0.4554801292300213
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.6084621502623961,0.4465685262527469
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.6172093177021909,0.4457445608075815
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.4455128243786568
RN2012_L13,0.5802164528023935,
LG2023_Control-1_intensity,0.6017024749891923,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.6156320066945875,0.45502431041872465
SR2019_SKBR3_Biol_repl_3,0.6053092342287231,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.6636581796695735,0.4509314805184049
HH2022_Reporter intensity 6,0.6009728610201038,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,0.6113092819481027,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.6156349382807603,0.4530391672961203
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,0.60212549825054,
AH2018_TMTMS2_3_X,0.6253181098239319,0.4619411633359767
GF2025_P3_Adh,0.6054201563860961,0.45608242416659817
SR2019_JIMT1_Biol_repl_2,0.588113580157685,
AH2018_TMTMS2_1_C,0.6312998795630682,0.4607784457487828
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5735154865985093,0.4562549871503815
KBE2022_Log2_Ex_19_U,0.6207137459093676,0.45378259569821366
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.6195970166652798,
AST2020_Control,0.6186483739673936,0.4422002477387509
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,0.612388024709551,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.6135760853229952,0.4506209965543594
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.6223274544985407,0.4540468083451198
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.6361833623572666,0.45689714100934326
HH2022_Reporter intensity 1,0.6336302932389887,
HH2022_Reporter intensity 2,0.6337166528954924,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.6124764011425806,0.44426545114198246
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.6118077282948194,0.44986275094381617
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.6158122674248072,0.45360042100046016
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.45231703560962605
AR2021_KD 72h,0.6319043661193783,0.4725903245187353
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.6096195549509243,0.4532570308702232
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.6226754152223875,
KBE2022_Log2_Ex_9_U,0.6070004255453912,0.45771553473297866
AH2018_SILAC_M_3_N,0.6333970557947801,0.4534994113829778
KBE2022_Log2_Ex_13_T,0.6118229956461023,0.4527505484377792
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,0.6059346597435,
PG2020_Intensity Mock_10h_C,0.6073836150613577,
CF2017_OSE 29,0.589789970853525,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.5965856790369015,0.4434322347428049
RN2012_L12,0.6160253557767805,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.6295303348923973,0.4531846051013801
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.6208445757252844,
KS2014_Intensity pY_PV3,0.6020259260309233,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.6042669482508324,0.44798511725601947
FSO2013_Ratio H/M normalized Rep2___2,,0.45234166192635306
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.6140086654495953,0.4395878920005047
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.6349103215789146,0.4497348347099875
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.6241854324027256,0.4534904988109466
CK2022_5 200-1,0.6243654579521907,0.45339826245061304
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.6192712816710207,0.4524670955760324
AH2018_SILAC_MR_1_X,0.6157009519923242,0.4512412454595074
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.6195120656544342,0.4468634023813324
AH2018_SILAC_3_C,0.6295553748514554,0.45319747058466253
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.45602343160309716
CK2022_4 16-1,,0.4452221765986571
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,0.5954819744448467,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.6219300040563905,0.4578361889565687
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.5908661008072724,0.4365584872326794
FSO2013_Ratio H/L normalized Rep3,,0.4623230981137926
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.6052583602981665,0.4580080527077384
AH2018_SILAC_IT_2_N,0.6152345829559625,0.4553141538109885
AH2018_SILAC_IT_1_X,0.6170067962298538,0.4476691517773463
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5933356074903238,0.4511908098655618
WZ2023_Pe_025_20min,0.6517347299052827,0.4570758610956986
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.62045471147391,0.454361662127787
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.6274264398175171,0.46049391280818874
RN2012_H06,0.6260671133943652,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.6570841921977222,0.4428541883158058
SR2019_HCC1419_Biol_repl_4,0.6073219421739121,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,0.589270131041678,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.625897440379876,0.463502748555798
WZ2023_Su_025_10min,0.6576215644551265,0.45254252661564165
AH2018_LFQ_IT_4_X,0.6261323699768807,0.4529283409153796
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.6607204080245079,0.44840012088702413
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5978533294123203,0.4552848021121722
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.6515429496814752,0.4584492784039991
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.6044211473790959,0.4496289502138241
LY2019_P7+,0.6161660853239073,0.4544330817567511
EP2017_Untreated R#1 normalized log2 ratio,0.627470686633331,0.45955986966136625
RN2012_L10,0.6129648268794647,0.4465005802378708
PG2020_Intensity 4h_C,0.5894941359969937,0.44491202924520123
EP2017_Mitotic R#3 normalized log2 ratio,0.5826606143061752,0.45630420031058894
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.6139410761876722,0.4399493669434921
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.6148838250139542,0.44563354955977375
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.6210140926574675,0.4145279312207017
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.6405342410495137,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.6322569051445394,0.4572646427273881
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5717071409345644,0.45637010348244444
GF2025_P9_Sph,0.6024858304495488,0.4512514335588745
CK2022_6 200-1,0.6238002228127988,0.4553025118069046
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.6260762793206001,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,0.5917685269584604,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,0.5984768909825116,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.5993711020001058,0.43977722829582583
EP2017_Untreated R#3 normalized log2 ratio,0.5679403488615566,0.45200880946921906
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.6244392848459681,0.45330645550919846
KS2014_Intensity pY_C4,0.6124058239845601,
CR2017_Ratio Replicate 3.5,0.597866494249254,0.44113741768350384
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5931375267044419,0.45700317341672453
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,0.6038537290543122,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.6191753975483847,0.4476329639249369
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.6075307047516697,0.4544319912252221
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.617853946667598,0.44909443471693694
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.600146052867976,0.438060916419656
PG2020_Intensity CT_C,0.62286094480908,0.44548900533396474
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,0.45846180280855126
KS2014_Intensity pY_PV4,0.5992081269348277,
KBE2022_Log2_Ex_39_U,0.6239589071801958,0.42470670302345936
EP2017_Untreated R#3 log2 ratio,0.5716455951931209,0.45265148601675814
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5982325881870134,0.44828090483896216
HS2024_8_PD_T2,,
FS2019_Ctr2,0.6030643063913763,0.4604083668081545
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.6205732377430688,0.4205674770409388
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.594019160743296,0.4472283131528417
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.6056833239156887,0.45658866832033684
YA2020_Reporter_intensity_Normal_No.2,0.6076398178100437,0.44855352601258014
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.6158493221412561,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.6250677117354801,0.4570235218794493
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.6139108110793059,0.4511575907591746
CK2022_2 16-1,,0.4440645902049856
RAM2015_Log2 B,0.6238931002355179,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,0.4570156380491685
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.6280281178468096,0.4528698374786164
WZ2023_Su_025_30min,0.6564347392552151,0.4542490186665531
AH2018_LFQ_4_N,0.6198419426433894,0.4528768710309158
CR2017_Ratio Replicate 1.2,0.645584366008245,0.4636530874207191
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.583665471356707,
AH2018_SILAC_M_1_X,0.6156470306543934,0.45618922417349295
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.6180298209842242,0.45229425322657646
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.6360747569290982,0.44914475070812304
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.6239487525531204,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.6391667565670007,0.45299389447420796
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.6250916276918389,0.4584223625829999
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,0.5960614886901471,
AH2018_LFQ_M_4_N,0.6243992665855898,0.4558283504649478
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5725660419472779,0.44646131310452286
AH2018_LFQ_2_X,0.6170713216856013,0.4542901289307789
PG2020_Intensity 2h_B,0.622900516422731,0.4489876676795662
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.6349920287265568,0.4535821543277815
GF2025_P3_Sph,0.5942988275931433,0.44770158999594345
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.6141560910971083,0.45458620061933397
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,0.4594883309874705
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.4507406380342182
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.6173897509797716,0.45552028174844705
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.6237726020637993,0.4561607809104566
ZQ2022_N1,,
LY2019_P6-,0.5911474262883966,0.44824196637395364
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.6066720802202675,
AH2018_LFQ_3_N,0.6164331463130608,0.4544831686079293
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.6227787132004556,0.4535283807839437
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.5990328468716326,0.45017072237020983
SR2019_BT549_Biol_repl_2,0.5968893177945712,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.6605171621168169,0.4491865873301622
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.6061626903900159,0.45538580050523636
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.45591381946442633
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.6145920132078786,0.45491862295978347
PG2020_Intensity 10h_D,0.6013620261989787,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.5921076373085901,0.45523384804296985
FSO2013_Ratio M/L normalized Rep1___3,,0.46334847485276864
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.6256302291301655,0.4516386212061927
AH2018_LFQ_M_4_C,0.6291938434925445,0.45854138728906857
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.639570501979974,
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.6254633268434244,0.4265966204728541
LY2019_P3-,0.6534166461831499,0.4496240028151203
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.6523359476537303,0.4563546040108067
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,0.6180263511220403,0.44238476725565185
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.6248709175991543,0.42848864110987106
FS2019_Ctr3,0.605422128425954,0.4600632508778344
WZ2023_Pu_025_20min,0.6563817673095566,0.45785733501698545
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.6182538145973162,0.4584011302853151
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,0.5886516723691975,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.6305196772177168,0.46142468622510774
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.6220211147656124,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.6164749654682959,0.45651664264867187
LY2019_P8+,0.5819149091723756,0.4560780048070163
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,0.6014046950188103,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.4554773636017379
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.6228241399770675,0.4516726529497078
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.6108832224327885,0.4406787081487617
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.613761446675501,
LY2019_P2-,0.5721060341771491,0.4501714647267436
AH2018_LFQ_IT_1_X,0.6150054529022092,0.45445259673499494
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.6553963001168314,0.4561098297090602
AST2020_Control.2,0.6180942240337469,0.44136833915406937
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,0.47053465696032787
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,0.6051031023169904,
KS2014_Intensity pY_C5,0.6119191075669699,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.6112785992025337,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.6140985702147764,0.4494273226772597
AH2018_TMTMS3_3_N,0.6200817996376086,
SR2019_HCC1419_Biol_repl_2,0.6077930721291388,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.6185065371217171,0.451988223510141
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5871493403795732,0.4567697116936805
KBE2022_Log2_Ex_36_T,0.6098028555138671,0.4499456272007025
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.6572926876348765,0.460240385388827
KS2014_Intensity C2,0.6261053606728378,0.45043301635295363
FSO2013_Ratio H/L normalized Rep1___2,,0.4493584898593025
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.6208881184792038,0.4307506721426432
CK2022_9 200-1,0.6275557107873461,0.4590951565320106
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.6273129915885702,0.45564266334406367
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.6029566389627232,0.45507162291202397
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.609847786410054,0.4413332103929079
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.6371936799892743,0.45344679047178416
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.6216436643024699,0.42765319364793364
FSO2013_Ratio H/M normalized Rep3___2,,0.45027405311813284
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.6314179433168854,0.46026846700627455
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.6605927635690025,0.45154447404249354
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,0.606949510674812,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.6370948820041046,0.4611852856609282
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.6353172939597643,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.6263597954038655,0.4495270562164116
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.6212926893257712,0.456111204355316
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.6149194068889676,0.45033143303076545
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.6205183444144763,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.6373263552147219,0.45550226532525284
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.6183476147237469,0.4421312506360719
SR2019_MDAMB231_Biol_repl_1,0.6003427269368949,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.6533902026396097,0.45698909928857345
KBE2022_Log2_Ex_29_U,0.6094718617985404,0.4537784873154558
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.6221485187803457,0.4572678873849981
AH2018_LFQ_IT_4_N,0.6282579882878598,0.453374376422914
CK2022_15 200-1,0.6319415255577255,0.45776859074735887
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.6149984551843354,0.43559057142929697
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.6365647445027296,0.45258056550191245
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.6241589228823454,0.44756475433895637
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.6606639336376567,0.4485047476275502
RN2012_H01,0.6357371693903672,0.4537163178890641
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.6000934312247825,0.4556507272035201
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.6078819213867852,0.449880610840047
KBE2022_Log2_Ex_44_U,0.6097790597722115,0.43096125162970694
WZ2023_Pe_010_20min,0.6527385143143857,0.45819923437801025
KS2014_Intensity pY_C6,0.6125242734791942,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.6381740213458115,0.447097213148524
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,0.6349133142089198,0.4533147316279448
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.61974865804739,0.4482789276122786
AH2018_SILAC_M_2_X,0.615818612060197,0.4460141924517694
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.6177729637747367,0.4227224021856556
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.6595672229416214,0.45386926476685713
PG2020_Intensity 6h_C,0.5872358008043802,0.4442189174231251
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.6210597970228633,0.45713490538785495
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.6305653230538452,0.46171705556032583
CK2022_15 16-1,,0.4415460401485173
CK2022_3 16-1,,0.4443299650811515
LY2019_P4-,0.6190315497058199,0.4556853360490451
FSO2013_Ratio H/L normalized Rep3___2,,0.4597042787702691
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.6222322090793078,0.45324407300714914
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.6120214629087253,0.4610128821360727
CK2022_10 16-1,,0.44193619798601513
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.4471154889253925
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5755008075174329,0.45668010840843537
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.6006508681394798,
AR2021_L41 10 μM,0.6109933340872318,0.4673377944716336
CF2017_EOC 2,0.6125546111988933,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.6146199721857465,0.4546792908265574
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,0.44665418618695013
ZX2022_CB treated Replicate 1,0.6463628877683685,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.6329650960637472,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.6264973086870637,0.46158867396329484
AR2021_L41 1 μM,0.612365860064588,0.4529148531616943
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.6296766438103917,0.4604466037243425
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.6341747771065462,
KS2014_Intensity C4,0.6384070407844831,0.45417098941515405
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.60139805255725,0.454750267326954
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,0.451169159212421
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,0.6010287575504479,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.6222742047770244,0.4598972836120435
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.6191289888942123,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.6135474094005761,0.458019263323867
WZ2023_Pu_025_10min,0.6532425522337963,0.4559020605639298
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,0.5933912682352785,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.6115884267653627,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.6535254521643531,0.4590644964198588
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.6172664161539517,0.44412169719715855
KS2014_Intensity C6,0.6354852632124102,0.4543331188855248
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.6415111531286122,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.6138166304647622,0.45785842081951217
CK2022_5 40-1,,
AH2018_LFQ_3_X,0.6186726884575947,0.45257976497121116
UK2020_UA_3,,
LY2019_P7-,0.634364887817753,0.4502059938797247
GF2025_P5_Adh,0.6030677583988613,0.45843669958304156
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,0.5928901487575498,
CR2017_Ratio Replicate 2.2,0.6052921506126945,0.47328802795971764
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,0.44529693081902944
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5853723233559452,0.44358783816583713
PG2020_Intensity CT_B,0.6212245780814499,0.43865753281499914
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.6215367379808922,0.45118047591145205
KS2014_Intensity pY_E5_1,0.6090453720819948,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,0.5846526581562091,0.4578609704421778
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.6173895490019891,0.4573822510430931
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.6233428989654027,0.4539017005219141
YA2020_Reporter_intensity_Cancer_No.4,0.6164510896095956,0.4460419879050689
KS2014_Intensity pY_E5_2,0.6095632705747855,
FSO2013_Ratio H/L normalized Rep1___3,,0.47078804561685184
GF2025_P4_Sph,0.6136017985890854,0.4570838801862124
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.6197432102447864,0.445433102500265
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,0.4463457658509733
AST2020_anti-CD3+PDL2,0.6179781448358936,0.44178818678826576
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.6222207043109346,0.4557573021852095
KS2014_Intensity pY_N1,0.6131166423202616,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,0.45683649667078463
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.57670201468568,0.4563760144424128
AH2018_TMTMS2_1_X,0.6272146586042948,0.4603827515159239
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,0.5990933935750594,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.6119264260905458,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.6149991547070741,0.4544457069794884
PG2020_Intensity 10h_B,0.5990347088042093,0.4403649574683749
AH2018_TMTMS3_1_X,0.6267660202859762,
CF2017_FTE 14,0.6045263073734626,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5628241155467768,0.44340806727477033
SR2019_HCC1419_Biol_repl_3,0.6049956969640549,
KBE2022_Log2_Ex_14_T,0.6244559664998688,0.4559646304524917
EP2017_Untreated R#2 normalized log2 ratio,0.6081737449426354,0.44955983930088134
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.629598637019775,0.465248699109162
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5897288080229166,0.4566126166757577
AS2011_Ratio H/L Normalized RNAi_2_1,,
